A super active cyclic hexapeptide analog of somatostatin.
暂无分享，去创建一个
D. Veber | R. Freidinger | R. Nutt | S. Brady | P. Curley | W. J. Paleveda | R. Saperstein | D. Perlow | C. D. Colton | A. G. Zacchei | Daniel F. Veber | A. Zacchei | Stephen F. Brady | Paul Curley | Christiane D. Colton | Dominick J. Tocco | Dale R. Hoff | Richard L. Vandlen | John E. Gerich | Larry Hall | Lawrence J. Mandarino | Eugene H. Cordes | Paul S. Anderson | Ralph Hirschmann | P. Anderson
[1] D. Veber,et al. Somatostatin analogs which define the role of the lysine-9 amino group. , 2009, International journal of peptide and protein research.
[2] P. Marbach,et al. SMS 201-995: a very potent and selective octapeptide analogue of somatostatin with prolonged action. , 1982, Life sciences.
[3] Ruth F. Nutt,et al. A potent cyclic hexapeptide analogue of somatostatin , 1981, Nature.
[4] D. Veber,et al. Inferences about the conformation of somatostatin at a biologic receptor based on NMR studies , 1978 .
[5] J. Gerich. Somatostatin modulation of glucagon secretion and its importance in human glucose homeostasis. , 1978, Metabolism: clinical and experimental.
[6] R. Mahler,et al. Glucagon and insulin relationships in the obese hyperglycemic mouse (ob/ob). , 1976, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[7] R. Unger. Glucagon physiology and pathophysiology. , 1971, The New England journal of medicine.
[8] C. Rerup. Drugs producing diabetes through damage of the insulin secreting cells. , 1970, Pharmacological reviews.